BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30007044)

  • 1. Conditional survival of patients with small renal masses undergoing active surveillance.
    Petros FG; Venkatesan AM; Kaya D; Ng CS; Fellman BM; Karam JA; Wood CG; Matin SF
    BJU Int; 2019 Mar; 123(3):447-455. PubMed ID: 30007044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy.
    Patel N; Cranston D; Akhtar MZ; George C; Jones A; Leiblich A; Protheroe A; Sullivan M
    BJU Int; 2012 Nov; 110(9):1270-5. PubMed ID: 22564495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced ultrasound (CEUS) imaging for active surveillance of small renal masses.
    Bertelli E; Palombella A; Sessa F; Baldi I; Morelli N; Verna S; Greco I; Morselli S; Pili A; Sebastianelli A; Berni A; Nicoletti R; Minervini A; Carini M; Gacci M; Miele V; Agostini S; Serni S; Campi R
    World J Urol; 2021 Aug; 39(8):2853-2860. PubMed ID: 33495864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of active surveillance of small renal masses.
    Volpe A
    Int J Surg; 2016 Dec; 36(Pt C):518-524. PubMed ID: 27321381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness of management options for patients with small renal masses: a prospective cohort study.
    Alam R; Patel HD; Osumah T; Srivastava A; Gorin MA; Johnson MH; Trock BJ; Chang P; Wagner AA; McKiernan JM; Allaf ME; Pierorazio PM
    BJU Int; 2019 Jan; 123(1):42-50. PubMed ID: 30019484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry.
    Pierorazio PM; Johnson MH; Ball MW; Gorin MA; Trock BJ; Chang P; Wagner AA; McKiernan JM; Allaf ME
    Eur Urol; 2015 Sep; 68(3):408-15. PubMed ID: 25698065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
    Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance.
    Mason RJ; Abdolell M; Trottier G; Pringle C; Lawen JG; Bell DG; Jewett MA; Klotz L; Rendon RA
    Eur Urol; 2011 May; 59(5):863-7. PubMed ID: 21353376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Clear Cell Likelihood Score on MRI and Growth Kinetics of Small Solid Renal Masses on Active Surveillance.
    Rasmussen RG; Xi Y; Sibley RC; Lee CJ; Cadeddu JA; Pedrosa I
    AJR Am J Roentgenol; 2022 Jan; 218(1):101-110. PubMed ID: 34286596
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse pathologic characteristics in the small renal mass: implications for active surveillance.
    Syed JS; Nawaf CB; Rosoff J; Bryson C; Nguyen KA; Suarez-Sarmiento A; Serrano M; Kibel AS; Humphrey P; Shuch B; Adeniran AJ
    Can J Urol; 2017 Apr; 24(2):8759-8764. PubMed ID: 28436365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
    Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
    J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: An analysis of the national cancer data base.
    Ristau BT; Handorf EA; Cahn DB; Kutikov A; Uzzo RG; Smaldone MC
    Cancer; 2018 Oct; 124(19):3839-3848. PubMed ID: 30207380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Renal Masses in an Octogenarian Cohort: Is There a Right Approach?
    Tang DH; Nawlo J; Chipollini J; Gilbert SM; Poch M; Pow-Sang JM; Sexton WJ; Spiess PE
    Clin Genitourin Cancer; 2017 Dec; 15(6):696-703. PubMed ID: 28566202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active Surveillance is Superior to Radical Nephrectomy and Equivalent to Partial Nephrectomy for Preserving Renal Function in Patients with Small Renal Masses: Results from the DISSRM Registry.
    Danzig MR; Ghandour RA; Chang P; Wagner AA; Pierorazio PM; Allaf ME; McKiernan JM
    J Urol; 2015 Oct; 194(4):903-9. PubMed ID: 25813449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of Delayed Intervention for Patients on Active Surveillance for Small Renal Masses: Does Renal Mass Biopsy Influence Our Decision?
    Ambani SN; Morgan TM; Montgomery JS; Gadzinski AJ; Jacobs BL; Hawken S; Krishnan N; Caoili EM; Ellis JH; Kunju LP; Hafez KS; Miller DC; Palapattu GS; Weizer AZ; Wolf JS
    Urology; 2016 Dec; 98():88-96. PubMed ID: 27450936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Growth Kinetics and Oncologic Outcomes of Patients Undergoing Active Surveillance for Residual Renal Tumor following Percutaneous Thermal Ablation.
    Chen JX; Maass D; Guzzo TJ; Bruce Malkowicz S; Wein AJ; Soulen MC; Clark TWI; Nadolski GJ; William Stavropoulos S
    J Vasc Interv Radiol; 2016 Sep; 27(9):1397-1406. PubMed ID: 27234485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active Surveillance for Localized Renal Masses: Tumor Growth, Delayed Intervention Rates, and >5-yr Clinical Outcomes.
    McIntosh AG; Ristau BT; Ruth K; Jennings R; Ross E; Smaldone MC; Chen DYT; Viterbo R; Greenberg RE; Kutikov A; Uzzo RG
    Eur Urol; 2018 Aug; 74(2):157-164. PubMed ID: 29625756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changeable Conditional Survival Rates and Associated Prognosticators in Patients with Metastatic Renal Cell Carcinoma Receiving First Line Targeted Therapy.
    Kang M; Park JY; Jeong CW; Hwang EC; Song C; Hong SH; Kwak C; Chung J; Sung HH; Jeon HG; Jeong BC; Park SH; Jeon SS; Lee HM; Choi HY; Seo SI
    J Urol; 2018 Nov; 200(5):989-995. PubMed ID: 29940249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active surveillance for small renal masses diagnosed in elderly or comorbid patients: looking for the best treatment strategy.
    Brunocilla E; Borghesi M; Schiavina R; Palmieri F; Pernetti R; Monti C; Martorana G
    Actas Urol Esp; 2014; 38(1):1-6. PubMed ID: 24126193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.